
Mukund Pharmatek Private Limited
About Mukund Pharmatek Private Limited
Data last updated:
Mukund Pharmatek Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the diversified financial services segment of the financial services sector. It was incorporated on 10 August 1990 and has been in existence for over 36 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74899DL1990PTC041146.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1.77 Lakh. It is led by directors including Sumit Aggarwal and Saurabh Aggarwalla.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 201 A Second Floor Dimension Vardhman Plaza Plot – 3 L.S.C. Indra Enclave, New Delhi, Delhi, India – 110041.
As per the financials filed for FY 2024, the company reported a revenue of ₹19.32 Lakh. For the same year it recorded a net profit of ₹1.01 Lakh (net margin 5.2%) and EBITDA of ₹1.87 Lakh (EBITDA margin 9.7%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years and 10% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Mukund Pharmatek Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address201 A Second Floor Dimension Vardhman Plaza Plot – 3 L.S.C. Indra Enclave, New Delhi, Delhi, India – 110041
- IndustryFinancial Services, Diversified Financial Services
To see the full contact details of Mukund Pharmatek Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Mukund Pharmatek is administrative and support service activities. In detail, this covers office administrative, office support and other business support activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| N | Administrative and support service activities | 82 | Office administrative, office support and other business support activities |
To see the full business activity and turnover split of Mukund Pharmatek Private Limited, buy the company report.
Financials of Mukund Pharmatek Private Limited
FY 2025 filings availableMukund Pharmatek Private Limited reported revenue of ₹19.32 Lakh for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 10% over five years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.87 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.01 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9.7% | ||||
| Net Profit Margin | 5.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Mukund Pharmatek Private Limited, buy the company report.
Board of directors of Mukund Pharmatek Private Limited
Mukund Pharmatek has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sumit Aggarwal Also directs: Shree Rani Sati Infotech Private Limited | Director | 02 Sep 2006 | 20 Years 2 Months | Current |
| Saurabh Aggarwalla Also directs: Shree Rani Sati Infotech Private Limited | Director | 02 Sep 2006 | 20 Years 2 Months | Current |
| Shashi Aggarwal Also directs: Shree Rani Sati Infotech Private Limited | Director | 31 Oct 2012 | 14 Years 0 Months | Current |
Auditor
Mukund Pharmatek Private Limited is audited by R K D S & ASSOCIATES for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| R K D S & ASSOCIATES | FY 2019 | 309091E |
Shareholding
The shareholding of Mukund Pharmatek Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Mukund Pharmatek Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Mukund Pharmatek Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Mukund Pharmatek Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Mukund Pharmatek Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Mukund Pharmatek Private Limited has 3 board changes on record since 2006: 3 appointments. The latest: Shashi Aggarwal was appointed as Director on 31 Oct 2012.
Frequently asked questions
Mukund Pharmatek is an active private limited company based in New Delhi, Delhi, India. The company works in diversified financial services, within the financial services industry. It was incorporated on 10 August 1990 (36+ years old) and is registered under CIN U74899DL1990PTC041146.
Mukund Pharmatek has 3 current directors:
- Sumit Aggarwal - Director
- Saurabh Aggarwalla - Director
- Shashi Aggarwal - Director
The latest financial statements of Mukund Pharmatek on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Mukund Pharmatek is U74899DL1990PTC041146. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mukund Pharmatek was incorporated on 10 August 1990, making it 36+ years old. It is registered with the Registrar of Companies, Delhi.
Shashi Aggarwal was appointed as Director on 31 Oct 2012. Saurabh Aggarwalla was appointed as Director on 02 Sep 2006. Sumit Aggarwal was appointed as Director on 02 Sep 2006.
The registered office of Mukund Pharmatek is at 201 A Second Floor Dimension Vardhman Plaza Plot – 3 L.S.C. Indra Enclave, New Delhi, Delhi, India – 110041.
Mukund Pharmatek operates in the financial services industry, in the diversified financial services segment.
The compliance status of Mukund Pharmatek is compliant as of 23 August 2026. The company is actively filing with the Registrar of Companies.
Mukund Pharmatek can be reached at its registered office: 201 A Second Floor Dimension Vardhman Plaza Plot – 3 L.S.C. Indra Enclave, New Delhi, Delhi, India – 110041.

